全球神经刺激设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计神经刺激设备市场规模将从 2025 年的 124.8 亿美元成长到 2034 年的 366.2 亿美元，2026 年至 2034 年的复合年增长率为 12.71%。

受神经系统疾病先进治疗方法需求不断增长的推动，全球神经刺激设备市场正经历强劲成长。神经刺激设备利用电脉衝刺激神经系统的特定区域，进而缓解慢性疼痛、帕金森氏症、癫痫和忧郁症症状。由于神经刺激器为对传统药物疗法反应不佳的患者提供了有效的治疗选择，因此医疗专业人员对其应用正在迅速增加。

推动该市场扩张的因素有很多。神经系统疾病和慢性疼痛的日益普遍，增加了对创新治疗方案的需求。此外，人们对微创疗法的认识也不断提高，也促使患者和医疗专业人员考虑使用神经刺激设备。持续的技术进步，例如电池续航时间的延长、无线编程以及植入式设备的小型化，也为市场成长提供了支援。

随着神经科学和医疗技术研究的不断深入，神经刺激设备的市场前景十分广阔。对医疗创新投入的增加以及神经系统专科治疗的普及将进一步推动其应用。此外，能够提供更精准刺激的新一代设备的研发有望改善治疗效果，并为市场创造新的机会。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球神经刺激设备市场：依产品划分

• 市场分析、洞察与预测
• 深部脑部刺激器
• 胃电刺激设备
• 脊髓刺激设备
• 荐骨神经刺激器
• 迷走神经刺激设备
• 经皮电神经刺激（TENS）
• 其他产品

第五章 全球神经刺激设备市场：依应用划分

• 市场分析、洞察与预测
• 疼痛管理
• 癫痫
• 自发性震颤
• 尿失禁和粪便失禁
• 忧郁症
• 肌张力不全症
• 胃轻瘫
• 帕金森氏症
• 其他用途

第六章 全球神经刺激设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioControl Medical
  • Boston Scientific Corporation
  • ElectroCore Inc
  • Endostim
  • Helbling Holding AG
  • Innovative Health Solutions Inc
  • Laborie Inc
  • LivaNova PLC
  • Medtronic Plc
  • MicroTransponder
  • Neuronetics Inc
  • Parasym Ltd
  • RS Medical

The Neurostimulation Devices Market size is expected to reach USD 36.62 Billion in 2034 from USD 12.48 Billion (2025) growing at a CAGR of 12.71% during 2026-2034.

The global neurostimulation devices market is experiencing strong growth due to increasing demand for advanced treatments for neurological disorders. Neurostimulation devices use electrical impulses to stimulate specific areas of the nervous system in order to manage conditions such as chronic pain, Parkinson's disease, epilepsy, and depression. Healthcare providers are increasingly adopting these devices as they offer effective treatment options for patients who do not respond well to conventional medications.

Several factors are driving the expansion of this market. The rising prevalence of neurological disorders and chronic pain conditions is increasing the demand for innovative treatment solutions. In addition, growing awareness about minimally invasive therapies is encouraging patients and healthcare professionals to consider neurostimulation devices. Continuous technological advancements, including improved battery life, wireless programming, and smaller implantable devices, are also supporting market growth.

The future of the neurostimulation devices market appears highly promising as research in neuroscience and medical technology continues to advance. Increasing investments in healthcare innovation and expanding access to specialized neurological treatments will likely support wider adoption. Furthermore, the development of next-generation devices capable of providing more precise stimulation is expected to enhance treatment effectiveness and create new opportunities in the market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Deep brain stimulator
• Gastric electric stimulator
• Spinal cord stimulator
• Sacral nerve stimulator
• Vagus nerve stimulator
• Transcutaneous electrical nerve stimulation (TENS)
• Other products

By Application

• Pain management
• Epilepsy
• Essential tremor
• Urinary and fecal incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's disease
• Other applications

COMPANIES PROFILED

• Abbott Laboratories, Aleva Neurotherapeutics SA, BioControl Medical, Boston Scientific Corporation, ElectroCore Inc, Endostim, Helbling Holding AG, Innovative Health Solutions Inc, Laborie Inc, LivaNova PLC, Medtronic plc, MicroTransponder, Neuronetics Inc, Parasym Ltd, RS Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Deep brain stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Gastric electric stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Spinal cord stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sacral nerve stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Vagus nerve stimulator Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Transcutaneous electrical nerve stimulation (TENS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Epilepsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Essential tremor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Urinary and fecal incontinence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Depression Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Dystonia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Gastroparesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Parkinson's disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Other applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROSTIMULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEUROSTIMULATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Aleva Neurotherapeutics S.A
  • 8.2.3 BioControl Medical
  • 8.2.4 Boston Scientific Corporation
  • 8.2.5 ElectroCore Inc
  • 8.2.6 Endostim
  • 8.2.7 Helbling Holding AG
  • 8.2.8 Innovative Health Solutions Inc
  • 8.2.9 Laborie Inc
  • 8.2.10 LivaNova PLC
  • 8.2.11 Medtronic Plc
  • 8.2.12 MicroTransponder
  • 8.2.13 Neuronetics Inc
  • 8.2.14 Parasym Ltd
  • 8.2.15 RS Medical